ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited' Solid Oral Formulation Facility (F-4) At Jarod

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Expensive Performer

984.0000 18.30 (1.89%)

NSE Jun 04, 2025 13:44 PM

35.69% Gain from 52W Low

Volume: 52,521

Alembic Pharmaceuticals Ltd.

23 Nov 2024

984.00

1.89%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited' Solid Oral Formulation …

BSE India

Please find attached the intimation for USFDA Inspection at Company''s Solid Oral Manufacturing Facility (F-4) at Jarod.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market trades higher, TPG to sell 2.1% stake in Tata Tech for Rs 634 crore via block deal

Trendlyne Marketwatch | 04 Jun 2025, 01:35PM

Five stocks to buy from analysts this week - June 03, 2025

The Baseline | 03 Jun 2025, 04:42PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals